US FDA Guidance Redefines Obesity, But Keeps 2007 Efficacy Standard

The US Food and Drug Administration updated obesity drug development draft guidance for the first time in almost 20 years and although a lot has changed in the field, the FDA’s fundamental expectations to support approval did not.